ATEL Ventures

Isar Aerospace is a space technology company focused on developing automated production methods for rockets. The company designs launch vehicles that facilitate the deployment and resupply of satellite constellations, aiming to provide low-cost and flexible access to space for small satellites. With an emphasis on sustainability, Isar Aerospace offers environmentally friendly solutions for propelling small launchers and upper-stage vehicles, thereby lowering entry barriers for clients seeking affordable and reliable space access.

Pendulum Therapeutics is a biotechnology company specializing in microbiome-targeted therapies. Founded in 2013 by experts in microbiology, biochemistry, computational science, and clinical research, the company develops evidence-based medical probiotics to manage chronic illnesses, with a focus on type 2 diabetes. Its flagship product, Pendulum Glucose Control, has demonstrated efficacy in lowering blood sugar spikes and reducing A1C levels in clinical trials.

ARRIS specializes in advanced manufacturing technologies, particularly in the development of performance composites for various mass-market applications, including aerospace, automotive, and consumer products. The company's innovative additive molding technology enables the production of 3D-aligned continuous fiber thermoplastic composite parts at scale. This proprietary process allows for the precise alignment of continuous carbon fibers and the integration of electronic components and multifunctional materials into a single, topology-optimized structure. By combining these elements, ARRIS provides clients with access to advanced composite solutions that enhance product performance and efficiency.

Astranis develops innovative satellite technology to provide targeted internet access to underserved regions. The company manufactures small satellites for high-orbit deployment, serving diverse sectors such as defense, commercial communications, oil and gas, and telecommunications.

Plant Prefab specializes in constructing custom single-family and multi-family homes using advanced prefabrication methods. Their proprietary Plant Building System employs digital modeling and modular components called Plant Panels and Plant Modules, allowing contractors and developers to complete projects 20-50% faster than traditional on-site construction. This system ensures superior quality control, design flexibility, and significant time, cost, and material efficiency. Committed to sustainability, Plant Prefab aims to build a better world by design, having achieved carbon-neutral operations since 2020 and being the first housing prefabricator to announce a net-zero goal.

Hexagon Bio, Inc. is a biotechnology company that specializes in discovering novel small molecule therapeutics by mining genomic data from fungal genomes. Founded in 2016 and headquartered in Menlo Park, California, Hexagon Bio leverages a proprietary platform that integrates data science, synthetic biology, and automation to identify and engineer drugs. The company's innovative approach focuses on developing targeted therapies for diseases with unmet medical needs by searching for evolutionarily refined molecules and their associated protein targets. Through its unique methodology, Hexagon Bio aims to uncover new medicines encoded within the global metagenome, ultimately striving to improve patient outcomes.

Activ Surgical Inc. is a digital surgery company based in Boston, Massachusetts, dedicated to enhancing surgical procedures through advanced technology. Established in 2014 and originally known as Omniboros Inc., the company specializes in developing a robotic surgery platform that integrates computer vision, artificial intelligence, and robotics. Its flagship product, the Smart Tissue Autonomous Robot (STAR), is designed to improve surgical efficiency, accuracy, and patient outcomes while reducing the risk of unintended complications. Activ Surgical's innovative, patent-protected surgical software facilitates augmented reality-based and AI-driven operations, thereby enhancing surgeons' intra-operative decision-making and fostering safer surgical practices.

Function of Beauty is a New York-based beauty brand founded in 2015 by Hien Nguyen, Joshua Maciejewski, and Zahir Dossa. The company specializes in personalized hair care, skin care, and body care products, allowing customers to create customized shampoos, conditioners, and styling products tailored to their individual hair profiles and specific goals. Function of Beauty emphasizes the use of high-quality ingredients, ensuring that its products are free from sulfates, parabens, phthalates, and mineral oils, which may be harmful to consumers. By focusing on personalization and safety, the brand aims to meet the unique beauty needs of each customer.

Apeel Sciences, based in California, addresses the global food waste crisis by developing plant-derived solutions that extend the shelf life of fresh produce. Founded in 2012, the company creates pre-and post-harvest products using natural plant extracts, such as Edipeel and Invisipeel, which protect fruits and vegetables from environmental factors and pre-harvest issues. These innovations effectively double the lifespan of harvested crops without refrigeration, helping to reduce spoilage and conserve resources like water and energy. By leveraging materials found in the skins, peels, and seeds of fruits and vegetables, Apeel aims to minimize food waste and promote sustainability throughout the supply chain. The company's efforts are supported by a range of private investors and philanthropic organizations.

Lightship is a company founded in 2018 that focuses on transforming clinical trials to enhance health equity globally. By leveraging digital health innovations and remote care, it aims to make clinical research more accessible and patient-centered. Lightship provides decentralized and hybrid clinical services that improve patient experience, retention, and trial diversity. Its approach expands the pool of potential participants by moving beyond traditional research centers, effectively meeting patients in their own environments. This strategy helps to eliminate the barriers and inefficiencies associated with conventional clinical trial models, ultimately making medical research more inclusive and effective.

Plant Prefab specializes in constructing custom single-family and multi-family homes using advanced prefabrication methods. Their proprietary Plant Building System employs digital modeling and modular components called Plant Panels and Plant Modules, allowing contractors and developers to complete projects 20-50% faster than traditional on-site construction. This system ensures superior quality control, design flexibility, and significant time, cost, and material efficiency. Committed to sustainability, Plant Prefab aims to build a better world by design, having achieved carbon-neutral operations since 2020 and being the first housing prefabricator to announce a net-zero goal.

Iron Ox, Inc. is an innovative company that specializes in developing robotics for crop harvesting and sustainable indoor farming systems. Founded in 2015 and headquartered in San Carlos, California, Iron Ox operates greenhouses in Gilroy, California, and Lockhart, Texas. The company utilizes a combination of robotics, plant science, and machine learning to cultivate fresh, pesticide-free produce, including various leafy greens and culinary herbs. Their flagship product, Angus, is an autonomous farm mobile robot designed to enhance agricultural efficiency. By focusing on sustainable practices, Iron Ox aims to minimize agriculture's environmental impact while improving the availability, quality, and flavor of its products for consumers.

Emulate is a biotechnology company that develops organ-on-a-chip human emulation technology to model how diseases, medicines, chemicals, and foods affect human health. Its platform includes lung, intestinal, liver, and skin organ chips that reproduce normal biology and disease states, enabling human-relevant insights beyond traditional cell culture or animal models. The company also provides drug development tools and instrumentation software to support research and development workflows for researchers across biotechnology, pharmaceutical, consumer health, cosmetics, chemical, food, and agrochemical sectors, as well as government agencies and academic institutions. Founded in 2013 and headquartered in Boston, Emulate aims to accelerate understanding of human biology and improve human health outcomes.

Emulate is a biotechnology company that develops organ-on-a-chip human emulation technology to model how diseases, medicines, chemicals, and foods affect human health. Its platform includes lung, intestinal, liver, and skin organ chips that reproduce normal biology and disease states, enabling human-relevant insights beyond traditional cell culture or animal models. The company also provides drug development tools and instrumentation software to support research and development workflows for researchers across biotechnology, pharmaceutical, consumer health, cosmetics, chemical, food, and agrochemical sectors, as well as government agencies and academic institutions. Founded in 2013 and headquartered in Boston, Emulate aims to accelerate understanding of human biology and improve human health outcomes.

Ionic Materials, Inc. is a Woburn, Massachusetts-based company that specializes in the development of solid polymer electrolyte materials for batteries. Founded in 1986, the company leverages a technology team with extensive expertise in polymer science and electrochemistry to create a groundbreaking polymer electrolyte that enhances battery safety, performance, and cost-effectiveness. This innovation challenges traditional battery design, which often requires trade-offs among safety, cost, and performance. Ionic Materials aims to address the needs of various industries by providing solutions that enable original equipment manufacturers and other manufacturers to innovate and meet market demands without the burden of developing new materials independently. By collaborating with core partners in the battery industry, Ionic is focused on bringing its advanced technology to market.

Edeniq Inc. is a biotechnology company focused on developing processes for converting cellulosic biomass into industrial sugars and cellulosic ethanol. Founded in 2006 and based in Visalia, California, Edeniq offers innovative technologies such as the Cellunator, a mixing and milling device that enhances starch extraction from corn, and the Pathway platform, which enables the production of cellulosic ethanol from existing corn ethanol plants. The company's proprietary Intellulose technology allows for seamless integration into current ethanol production facilities without requiring significant capital investment. Edeniq licenses its technologies to bio-refineries in the United States and Brazil, helping them to increase throughput, improve yields, and produce valuable biofuels and biochemicals.

iPierian is a biotechnology company specializing in the development of therapies for neurodegenerative diseases. Utilizing induced pluripotent stem cells, the company focuses on addressing significant unmet medical needs, particularly in conditions such as spinal muscular atrophy, amyotrophic lateral sclerosis, and Parkinson's disease. iPierian is engaged in the research and development of innovative therapies, including monoclonal antibodies aimed at treating Alzheimer's disease and other Tauopathies. By targeting the mechanisms that drive disease progression, the company aims to provide physicians with effective tools to slow the spread of Tau in the brain, thereby potentially improving patient outcomes.

SolFocus's mission is to enable solar energy generation at a Levelized Cost of Energy (LCOE) competitive with traditional fossil fuel sources. To achieve this goal, SolFocus has developed leading concentrator photovoltaic (CPV) technology which combines high-efficiency solar cells (approaching 40%) and advanced optics to provide solar energy solutions which are scalable, dependable and capable of delivering on the promise of clean, low-cost, renewable energy.

NexPlanar Corporation specializes in the manufacturing of chemical mechanical planarization (CMP) pads for the semiconductor device industry. Founded in 2003 and based in Hillsboro, Oregon, the company also operates a manufacturing facility in Hopkins, Minnesota. NexPlanar's innovative products, which include hard, mid-hard, and ultra-soft pads, utilize proprietary nano-domain technology and patented molded grooves to enhance the efficiency of semiconductor fabrication processes. This technology allows for the tuning of pads to achieve improved yields and lower costs of ownership through extended pad life. Originally known as Neopad Technologies Corporation, the company rebranded to NexPlanar in September 2008 and has since become a subsidiary of Cabot Microelectronics Corporation.

IntelePeer is a communications automation platform that utilizes generative AI to enhance customer interactions for businesses. By offering a cloud-based Communications Platform as a Service (CPaaS), the company provides on-demand IP communications and SIP trunking services tailored for enterprises. IntelePeer's platform integrates seamlessly with existing systems, allowing businesses to streamline their communication processes across multiple channels. Its focus on automation not only reduces operational costs but also improves customer experience by delivering efficient and effective communication solutions. The incorporation of AI and analytics further enhances the platform's capabilities, enabling clients to achieve higher levels of customer satisfaction and engagement.

Dimension Data, formerly known as OpSource, is a provider of cloud and managed hosting solutions designed to help businesses of all sizes accelerate growth and scale operations effectively. Established in 2002, the company offers a comprehensive Application Operations service that surpasses traditional hosting by delivering application management, change management, performance management, and application optimization. This approach allows clients to benefit from the flexibility, availability, and community of public cloud services while ensuring the security, performance, and control required by enterprise environments. Dimension Data is certified with SAS 70 Type II, PCI DSS Level 1, and adheres to European Safe Harbor standards, with operations in California, Virginia, the UK, Ireland, and India. The company supports over four hundred Software-as-a-Service independent software vendors, cloud platform providers, carriers, and enterprises, enabling them to manage high-availability, business-critical hosting environments efficiently.

Enerkem transforms non-recyclable waste into renewable biofuels and chemicals. Its proprietary thermochemical process converts municipal solid waste into biofuels like ethanol, addressing oil dependence and waste disposal challenges.

GangaGen, Inc. is a biotechnology company based in Palo Alto, California, with research and development operations in Bangalore, India. Founded in 2000, GangaGen focuses on the discovery and development of novel therapeutic proteins aimed at preventing and treating infectious diseases, particularly those caused by antibiotic-resistant bacteria. The company utilizes a proprietary platform to create highly-specific therapeutic proteins known as ectolysins. Its lead product, P128, is a recombinant protein designed to target and eliminate Staphylococcus, including methicillin-resistant strains like MRSA. GangaGen's innovative approach also addresses infections caused by multidrug-resistant bacteria, such as Klebsiella pneumonia, enabling effective treatments for serious conditions like pneumonia and neonatal sepsis.

Innovalight, founded by Conrad Burke, specializes in the development of high-efficiency, low-cost solar modules aimed at both residential and commercial applications. The company is notable for its innovative approach to solar technology, utilizing a proprietary silicon ink that has been in development since 2005. This liquid-based processing method significantly enhances the cost-effectiveness and efficiency of solar modules compared to traditional solid or gas processing techniques. Innovalight's focus on ultra thin-film power modules positions it as a key player in the solar energy sector, particularly in the realm of grid-connected solar power generation.

Axial Biotech is a privately held, venture-backed company founded in 2002 by a group of internationally recognized spine surgeons and geneticists. Axial Biotech is focused on developing and commercializing genetic tests and treatment solutions for spinal disorders.

BuyerLink operates an online marketing platform that enables advertisers and publishers to acquire locally targeted, category-specific consumers through cost-per-click or cost-per-lead campaigns. The platform provides widgets for automotive, real estate, home improvement, mortgage, travel, and insurance, serving businesses of all sizes by eliminating the need for complex and expensive online marketing infrastructures and offering a cost-efficient alternative to major search engines and ad networks. Founded in 2001 and based in Walnut Creek, California, the company originated as Reply.com and rebranded to BuyerLink in 2015, focusing on making internet marketing accessible for local and category-specific campaigns and facilitating efficient lead generation for advertisers.

Cornice, Inc. provides storage elements for consumer electronics devices. Its storage element is built into various consumer products, including mobile phones, MP3 players, personal video recorders, GPS devices, and portable storage products. The company offers Crash Guard, which consists of active latch, skip control, and drop safe. It serves consumer electronics manufacturers. The company was founded in 2000 and is headquartered in Longmont, Colorado with integration centers in Hong Kong, Japan, and Taiwan.

Aryx Therapeutics is a biopharmaceutical company that specializes in the development of innovative oral therapies aimed at chronic diseases. The company leverages its expertise in retrometabolic drug design to create product candidates that address and eliminate safety concerns associated with existing, commercially successful medications. By focusing on improving the safety profiles of these therapies, Aryx Therapeutics seeks to enhance patient outcomes and provide better treatment options in the pharmaceutical market. The company's commitment to advancing drug safety is supported by a strong portfolio of intellectual property.